BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18824898)

  • 1. Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Staphylococcus aureus.
    Murphey ED; Fang G; Sherwood ER
    Crit Care Med; 2008 Nov; 36(11):3067-73. PubMed ID: 18824898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Pseudomonas aeruginosa.
    Murphey ED; Sherwood ER
    Microbes Infect; 2008 Oct; 10(12-13):1244-50. PubMed ID: 18678270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus.
    Murphey ED; Fang G; Sherwood ER
    Shock; 2008 Apr; 29(4):512-8. PubMed ID: 17724430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance.
    O'Brien GC; Wang JH; Redmond HP
    J Immunol; 2005 Jan; 174(2):1020-6. PubMed ID: 15634926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
    Yoshimura A; Lien E; Ingalls RR; Tuomanen E; Dziarski R; Golenbock D
    J Immunol; 1999 Jul; 163(1):1-5. PubMed ID: 10384090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction.
    Zhu X; Bagchi A; Zhao H; Kirschning CJ; Hajjar RJ; Chao W; Hellman J; Schmidt U
    Crit Care Med; 2007 Mar; 35(3):886-92. PubMed ID: 17255871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia.
    Kielian T; Esen N; Bearden ED
    Glia; 2005 Mar; 49(4):567-76. PubMed ID: 15593098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
    Takeuchi O; Hoshino K; Kawai T; Sanjo H; Takada H; Ogawa T; Takeda K; Akira S
    Immunity; 1999 Oct; 11(4):443-51. PubMed ID: 10549626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Staphylococcus aureus whole bacteria mutated in putative pro-inflammatory membrane components have similar cytokine inducing activity.
    Rockel C; Hartung T; Hermann C
    Immunobiology; 2011 Mar; 216(3):316-21. PubMed ID: 20965605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of pretreatment with TLR2 agonist Pam3Csk4 on mice challenged by methicillin-resistant Staphylococcus aureus].
    Chen Y; Chen H; Deng L; Gui X; Yu L; Xiong Z; Min W; Wu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):212-6. PubMed ID: 26927383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria.
    Laflamme N; Echchannaoui H; Landmann R; Rivest S
    Eur J Immunol; 2003 Apr; 33(4):1127-38. PubMed ID: 12672079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus.
    Kochan T; Singla A; Tosi J; Kumar A
    Infect Immun; 2012 Jun; 80(6):2076-88. PubMed ID: 22431652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands.
    Mullaly SC; Kubes P
    J Immunol; 2006 Dec; 177(11):8154-63. PubMed ID: 17114491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88.
    Sun Y; Hise AG; Kalsow CM; Pearlman E
    Infect Immun; 2006 Sep; 74(9):5325-32. PubMed ID: 16926427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma.
    Murphey ED; Fang G; Varma TK; Sherwood ER
    Shock; 2007 Mar; 27(3):289-95. PubMed ID: 17304110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of Staphylococcus aureus by the innate immune system.
    Fournier B; Philpott DJ
    Clin Microbiol Rev; 2005 Jul; 18(3):521-40. PubMed ID: 16020688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of key pathogenic factors from gram-positive bacteria by the soluble ectodomain of the scavenger-like lymphocyte receptor CD6.
    Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Cañadas O; Armiger-Borràs N; Bonet-Roselló L; Farrán A; Vila J; Casals C; Lozano F
    J Infect Dis; 2014 Apr; 209(7):1077-86. PubMed ID: 24265437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 and 6 interdependency in the erosive stage of Staphylococcus aureus induced septic arthritis mediated by IFN-γ and IL-6--A possible involvement of IL-17 in the progression of the disease.
    Ghosh C; Bishayi B
    Immunobiology; 2015 Jul; 220(7):910-23. PubMed ID: 25698349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression.
    Kielian T; Mayes P; Kielian M
    J Neuroimmunol; 2002 Sep; 130(1-2):86-99. PubMed ID: 12225891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation.
    Li B; Li J; Pan X; Ding G; Cao H; Jiang W; Zheng J; Zhou H
    Int Immunopharmacol; 2010 Mar; 10(3):344-50. PubMed ID: 20005985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.